Target intelligence / Profile preview

Microbiota composition

Molecular classification
Other (as it represents a community-level attribute, not a molecular classification; microbiota themselves are mostly bacteria, archaea, viruses, and fungi)
01

Overview

Microbiota composition describes the identity, abundance, and diversity of microbes (including bacteria, archaea, viruses, and fungi) present at a given anatomical or environmental site. Its assessment is central to understanding host-microbe interactions, metabolic and immune regulation, and disease mechanisms. Changes in microbiota composition—termed dysbiosis—have been linked to numerous diseases, and therapies now exist to manipulate these communities via antibiotics, probiotics, prebiotics, and interventions such as fecal microbiota transplantation. However, microbiota composition is not itself a molecular target, but rather a community-level metric, used to design and evaluate therapeutic approaches, identify biomarkers, and monitor efficacy and safety in translational research[1][2][3][4][5][6].

Other names
microbial community compositionmicrobial taxa abundancemicrobial diversity
02

Mechanism of action

The mechanism of action for interventions targeting microbiota composition involves the alteration of microbial abundance and diversity, selective elimination of pathogenic taxa, addition of beneficial microorganisms, and modulation of microbial metabolic activities.

03

Biological functions

Nutrient metabolismImmune modulationColonization resistanceProduction of metabolites (e.g., short-chain fatty acids)Protection against pathogensVitamin biosynthesis
04

Disease associations

InflammationMetabolic diseaseCancerCardiovascular diseaseNeurodegenerative diseaseInfectionOther (many emerging roles across immune, metabolic, and neurological health)
05

Safety considerations

Unpredictable effects of ecosystem perturbation (e.g., antibiotic-induced dysbiosis)Transmission of pathogens (especially in fecal transplantation)Long-term stability of engrafted microbiotaPotential for immune overactivation or tolerance breakdown
06

Interacting drugs

Antibiotics

3 more in the full profile.

07

Biomarkers

Shifts in taxonomic abundance (e.g., Firmicutes/Bacteroidetes ratio)Detection of specific pathogenic or beneficial taxa (e.g., Clostridioides difficile, Faecalibacterium prausnitzii)Microbial richness/diversity indicesMetabolite profiles (short-chain fatty acids, lipopolysaccharide levels, etc.)

Beyond the preview

Go deeper on Microbiota composition.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microbiota composition.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call